RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I

Journal of Virology

Volumn 85, Issue 3, 2011, Pages 1224-1236

  Solis, Mayra ^a,b   Nakhaei, Peyman ^a,b   Jalalirad, Mohammad ^a   Lacoste, Judith ^b   Douville, Renée ^a,b   Arguello, Meztli ^a   Zhao, Tiejun ^a   Laughrea, Michael ^a   Wainberg, Mark A ^a,b   Hiscott, John ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; INTERFERON; INTERFERON REGULATORY FACTOR 3; RETINOIC ACID INDUCIBLE PROTEIN I; RNA HELICASE; VIRUS RNA;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; CYTOSOL; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; LYSOSOME; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROVIRUS; SIGNAL TRANSDUCTION; VIRUS REPLICATION; WILD TYPE;

CELLS, CULTURED; DEAD-BOX RNA HELICASES; HIV PROTEASE; HIV-1; HUMANS; IMMUNE EVASION; INTERFERON REGULATORY FACTOR-3; INTERFERONS; MACROPHAGES; PROTEIN BINDING; RNA, VIRAL; SIGNAL TRANSDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78651401005     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01635-10     Document Type: Article

References (81)

1. Baenziger, S., et al. 2009. Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 113:377-388.
2. Baum, A., R. Sachidanandam, and A. Garcia-Sastre. 2010. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. U. S. A. 107:16303-16308.
3. Beignon, A. S., et al. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115:3265-3275.
4. Blanco, R., L. Carrasco, and I. Ventoso. 2003. Cell killing by HIV-1 protease. J. Biol. Chem. 278:1086-1093.
5. Boasso, A., and G. M. Shearer. 2008. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin. Immunol. 126:235-242.
6. Bowie, A. G., and L. Unterholzner. 2008. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8:911-922.
7. Brenchley, J. M., et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371.
8. Chin, M. P., J. Chen, O. A. Nikolaitchik, and W. S. Hu. 2007. Molecular determinants of HIV-1 intersubtype recombination potential. Virology 363:437-446.
9. Chin, M. P., T. D. Rhodes, J. Chen, W. Fu, and W. S. Hu. 2005. Identification of a major restriction in HIV-1 intersubtype recombination. Proc. Natl. Acad. Sci. U. S. A. 102:9002-9007.
10. Clerzius, G., et al. 2009. ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication. J. Virol. 83:10119-10128.
11. Coffin, J. M. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, NY.
12. Cullen, B. R. 2006. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 80:1067-1076.
13. Doehle, B. P., F. Hladik, J. P. McNevin, M. J. McElrath, and M. Gale, Jr. 2009. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J. Virol. 83:10395-10405.
14. Douville, R. N., and J. Hiscott. 2010. The interface between the innate interferon response and expression of host retroviral restriction factors. Cytokine 52:108-115.
15. Dube, M., et al. 2010. Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 6:e1000856.
16. Ehrlich, E. S., and X. F. Yu. 2006. Lentiviral Vif: viral hijacker of the ubiquitin-proteasome system. Int. J. Hematol. 83:208-212.
17. Frigault, M. M., J. Lacoste, J. L. Swift, and C. M. Brown. 2009. Live-cell microscopy - tips and tools. J. Cell Sci. 122:753-767.
18. Fu, W., R. J. Gorelick, and A. Rein. 1994. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and proteasedefective virions. J. Virol. 68:5013-5018. (Pubitemid 24226568)
19. Gringhuis, S. I., et al. 2010. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 11:419-426.
20. Heil, F., et al. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:1526-1529.
21. Herbein, G., and A. Varin. 2010. The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7:33.
22. Herbeuval, J. P., and G. M. Shearer. 2007. HIV-1 immunopathogenesis: how good interferon turns bad. Clin. Immunol. 123:121-128.
23. Hiscott, J., R. Lin, P. Nakhaei, and S. Paz. 2006. MasterCARD: a priceless link to innate immunity. Trends Mol. Med. 12:53-56.
24. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644-658.
25. Hong, S., J. Cao, and Y. T. Tu. 2009. Evolution of HIV-1 in a patient population failing multiple-drug therapy. Microbiol. Immunol. 53:535-539.
26. Hornung, V., et al. 2006. 5′-triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
27. Ito, M., et al. 1998. HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 14:845-849.
28. Jalalirad, M., and M. Laughrea. 2010. Formation of immature and mature genomic RNA dimers in wild-type and protease-inactive HIV-1: differential roles of the Gag polyprotein, nucleocapsid proteins NCp15, NCp9, NCp7, and the dimerization initiation site. Virology 407:225-236.
29. Kafaie, J., R. Song, L. Abrahamyan, A. J. Mouland, and M. Laughrea. 2008. Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging. Virology 375:592-610.
30. Kang, D. C., et al. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U. S. A. 99:637-642.
31. Kato, H., et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28.
32. Kato, H., et al. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205:1601-1610.
33. Kato, H., et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
34. Kawai, T., and S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137.
35. Kawai, T., et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
36. Kirchhoff, F. 2010. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67.
37. Li, K., Z. Chen, N. Kato, M. Gale, Jr., and S. M. Lemon. 2005. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 280:16739-16747.
38. Lin, R., et al. 2006. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J. Virol. 80:6072-6083.
39. Maitra, R. K., et al. 1994. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204:823-827.
40. Malathi, K., B. Dong, M. Gale, Jr., and R. H. Silverman. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448:816-819.
41. Maniatis, T., et al. 1998. Structure and function of the interferon-beta enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63:609-620.
42. Matikainen, S., et al. 2006. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J. Virol. 80:3515-3522.
43. Meier, A., et al. 2007. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J. Virol. 81:8180-8191.
44. Menees, T. M., B. Muller, and H. G. Krausslich. 2007. The major 5′ end of HIV type 1 RNA corresponds to G456. AIDS Res. Hum. Retroviruses 23:1042-1048.
45. Meylan, E., et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. (Pubitemid 41509355)
46. Mirani, M., et al. 2002. HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J. Immunol. 169:6361-6368.
47. Moore, M. D., and W. S. Hu. 2009. HIV-1 RNA dimerization: it takes two to tango. AIDS Rev. 11:91-102.
48. Nakhaei, P., P. Genin, A. Civas, and J. Hiscott. 2009. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin. Immunol. 21:215-222.
49. Neil, S. J., T. Zang, and P. D. Bieniasz. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430.
50. Nie, Z., et al. 2002. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ. 9:1172-1184.
51. Okumura, A., et al. 2008. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373:85-97.
52. Papon, L., et al. 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393:311-318.
53. Paz, S., et al. 2006. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway. Cell. Mol. Biol. (Noisy-le-Grand) 52:17-28.
54. Pichlmair, A., et al. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997-1001.
55. Plumet, S., et al. 2007. Cytosolic 5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2:e279.
56. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
57. Rehwinkel, J. 2010. Exposing viruses: RNA patterns sensed by RIG-I-like receptors. J. Clin. Immunol. 30:491-495.
58. Rehwinkel, J., et al. 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140:397-408.
59. Romieu-Mourez, R., et al. 2006. Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. Cancer Res. 66:10576-10585. (Pubitemid 44799781)
60. Saito, T., D. M. Owen, F. Jiang, J. Marcotrigiano, and M. Gale, Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523-527.
61. Schlee, M., et al. 2009. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31:25-34.
62. Schmidt, A., et al. 2009. 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc. Natl. Acad. Sci. U. S. A. 106:12067-12072.
63. Servant, M. J., N. Grandvaux, B. R. tenOever, D. Duguay, R. Lin, and J. Hiscott. 2003. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278:9441-9447.
64. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
65. Sharma, S., B. R. tenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151.
66. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
67. Solis, M., et al. 2006. Gene expression profiling of the host response to HIV-1 B, C, or A/E infection in monocyte-derived dendritic cells. Virology 352:86-99. (Pubitemid 44160713)
68. Song, R., J. Kafaie, L. Yang, and M. Laughrea. 2007. HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization. J. Mol. Biol. 371:1084-1098.
69. Takahasi, K., et al. 2008. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29:428-440.
70. Vahey, M. T., et al. 2002. Impact of viral infection on the gene expression profiles of proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF. AIDS Res. Hum. Retroviruses 18:179-192.
71. Van Damme, N., et al. 2008. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3:245-252.
72. Vazquez, N., et al. 2005. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J. Virol. 79:4479-4491.
73. Vendrame, D., M. Sourisseau, V. Perrin, O. Schwartz, and F. Mammano. 2009. Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer. J. Virol. 83:10527-10537.
74. Wang, F., et al. 2008. RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages. PLoS Pathog. 4:e1000099.
75. Watts, J. M., et al. 2009. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460:711-716.
76. Wilkins, C., and M. Gale, Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22:41-47.
77. Woelk, C. H., et al. 2004. Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res. Hum. Retroviruses 20:1210-1222.
78. Xu, L. G., et al. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727-740.
79. Yan, N., A. D. Regalado-Magdos, B. Stiggelbout, M. A. Lee-Kirsch, and J. Lieberman. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11:1005-1013.
80. Yoneyama, M., et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
81. Zhou, Y., et al. 2008. The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30. Virology 372:97-106.